• MPNRF | November 7, 2018

    The MPN Research Foundation has an exciting announcement to make! This fall, in collaboration with MPN Advocacy & Education Int’lThe Leukemia & Lymphoma Society and UT Health San Antonio MD Anderson Cancer Center, MPNRF will be holding an externally led patient-focused drug development (PFDD) meeting with the U.S. Food and Drug Administration (FDA).

    This meeting is a long-awaited opportunity for the MPN community to stand in front of decision makers like FDA regulators, academic researchers, and industry players to convey the challenges that ET, PV, and MF patients face every day. Our primary objective is to give MPN patients a platform so that they can share with the world what it means to have an MPN diagnosis, which of their symptoms should be prioritized, and how their disease impacts their quality of life.